# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA680068 | F | Antagonist activity against Gamma-aminobutyric acid A (GABA-A) receptor | Rattus norvegicus | 1 | assay format | Scientific Literature | ||
2. | ALA1216998 | F | Antimicrobial activity against Trypanosoma cruzi | Trypanosoma cruzi | 269 | organism-based format | Scientific Literature | ||
3. | ALA1216999 | F | Antimicrobial activity against Trypanosoma brucei brucei | Trypanosoma brucei brucei | 251 | organism-based format | Scientific Literature | ||
4. | ALA1217000 | F | Antimicrobial activity against Plasmodium falciparum | Plasmodium falciparum | 630 | organism-based format | Scientific Literature | ||
5. | ALA1217001 | F | Antimicrobial activity against Trypanosoma brucei | Trypanosoma brucei | 235 | organism-based format | Scientific Literature | ||
6. | ALA1217002 | F | Antimicrobial activity against Leishmania | Leishmania | 207 | assay format | Scientific Literature | ||
7. | ALA1217004 | F | Antimicrobial activity against Trichomonas vaginalis | Trichomonas vaginalis | 244 | organism-based format | Scientific Literature | ||
8. | ALA1217005 | F | Antimicrobial activity against Toxoplasma gondii | Toxoplasma gondii | 232 | organism-based format | Scientific Literature | ||
9. | ALA1217006 | F | Antimicrobial activity against Leishmania mexicana | Leishmania mexicana | 207 | organism-based format | Scientific Literature | ||
10. | ALA1217007 | F | Antimicrobial activity against Entamoeba histolytica | Entamoeba histolytica | 304 | organism-based format | Scientific Literature | ||
11. | ALA1217008 | F | Antimicrobial activity against Leishmania amazonensis | Leishmania amazonensis | 207 | organism-based format | Scientific Literature | ||
12. | ALA1217009 | F | Antimicrobial activity against Leishmania donovani | Leishmania donovani | 287 | organism-based format | Scientific Literature | ||
13. | ALA1217010 | F | Antimicrobial activity against Leishmania infantum | Leishmania infantum | 273 | organism-based format | Scientific Literature | ||
14. | ALA1217011 | F | Antimicrobial activity against Leishmania major | Leishmania major | 211 | organism-based format | Scientific Literature | ||
15. | ALA1217012 | F | Antimicrobial activity against Cryptosporidium parvum | Cryptosporidium parvum | 258 | organism-based format | Scientific Literature | ||
16. | ALA1217013 | F | Antimicrobial activity against Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | 232 | organism-based format | Scientific Literature | ||
17. | ALA1217186 | F | Antimicrobial activity against Pneumocystis carinii | Pneumocystis carinii | 209 | organism-based format | Scientific Literature | ||
18. | ALA4303810 | F | Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits) | Homo sapiens | 1,629 | organism-based format | SARS-CoV-2 Screening Data 2020-21 | ||
19. | ALA4423887 | B | Inhibition of TEAD in human HeLa cells assessed as reduction in CCN1 m-RNA expression incubated for 2 hrs followed by compound wash out and re-treatment for 4 hrs by by NanoGlo assay | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
20. | ALA4423888 | B | Inhibition of TEAD in human HeLa cells assessed as reduction in CTGF m-RNA expression incubated for 2 hrs followed by compound wash out and re-treatment for 4 hrs by by NanoGlo assay | Homo sapiens | 2 | cell-based format | Scientific Literature |